Danbury Hospital Biomedical Research Institute
Danbury Hospital has joined the ranks of leading research institutions nationwide with the Department of Medical Education and Research opening of the Danbury Hospital Biomoedical Research Institute, placing us at the forefront of molecular science research and personalized medicine.
The Danbury Hospital Biomedical Research Institute includes a team of internationally renowned physician scientists known for their groundbreaking work in the field of cancer and proteomics. The goal is to provide the highest-level of care by bringing evidence-based research findings to patients in clinical settings as soon and safely as possible.
Modern research facility
Located at 131 West St. in Danbury, the state-of-the-art Institute will initially focus on women’s reproductive cancers with the Reproductive Tumor Biology Research Laboratory. Research will eventually expand to other medical disciplines such as cardiovascular and Lyme disease.
The 17,000-square-facility complements the ongoing research being conducted at the hospital, including clinical trials and epidemiologic studies. The Research Institute will eventually house dozens of basic science researchers in a myriad of fields, sharing resources and expertise across institutional and disciplinary lines.
A new era of drug discovery begins
The Research Institute’s opening marks the start of a new frontier for the development of novel drugs and the identification of biomarkers that could help clinicians to more efficiently select current therapies.
Scientists are creating a custom-designed proteomics platform that will provide the foundation for molecular research well into the future. The innovative platform enables scientists to conduct molecular research that examines the structure, function and complexities of protein-protein interactions.
Researchers are screening thousands of compounds for their ability to inhibit protein-protein interactions associated with the most aggressive tumors in several tissues, including ovary, colon, prostate and lung.
Patient benefits of biomedical research
The potential patient benefits of this research include the development of:
- New drugs and less toxic therapies that target cancer cells while sparing healthy health tissue
- More effective personalized drugs based on an individuals’ unique proteomic expression
- New diagnostic techniques using protein biomarkers to identify people who are at risk or who are likely to resist certain treatment regimens
For More Information
If you would like to know more about the Danbury Hospital Biomedical Research Institute, please contact the Department of Medical Education and Research.
To learn more about Danbury Hospital, please visit the patient and visitor section of this website.